Leaflet TAMBOCOR 100 100mg tablets


Indicated for: cardiac arrhythmias

Route of administration: oral

Substance: flecainide (antiarrhythmic)

ATC: C01BC04 (Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class Ic)

Precautions:
Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Cardiac risk / QT prolongation / arrhythmias
Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.


Flecainide is a medication used to treat certain types of heart rhythm disorders, known as arrhythmias. This medicine helps restore the normal rhythm of the heart and prevents irregular or excessively fast heartbeats, which can be dangerous to your health. Flecainide is usually prescribed to patients who have experienced episodes of atrial fibrillation, ventricular tachycardia, or other supraventricular arrhythmias.

Flecainide is typically taken orally in tablet form, with the dose determined by the doctor based on each patient's needs. It is important to follow the treatment exactly as prescribed, without changing the dose or stopping the medication without your doctor's approval, as this can worsen symptoms or cause complications.

Side effects of flecainide may include dizziness, fatigue, blurred vision, palpitations, or a sensation of irregular heartbeats. In rare cases, more serious reactions can occur, such as worsening arrhythmias or severe allergic reactions. If you experience unusual or severe symptoms, it is important to contact your doctor immediately.

Flecainide is an effective medication for controlling arrhythmias, but it requires careful monitoring by the medical team. During treatment, periodic tests and electrocardiograms may be needed to check the effectiveness and safety of the therapy. Be sure to inform your doctor about any other medications or supplements you are taking to avoid unwanted interactions.

TAMBOCOR 100 100mg tablets MEDA, flecainide

General data about TAMBOCOR 100 100mg

  • Substance: flecainide
  • Date of last drug list: 01-01-2019
  • Commercial code: W52911005
  • Concentration: 100mg
  • Pharmaceutical form: tablets
  • Quantity: 100
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: 3M HEALTH CARE LTD. - MAREA BRITANIE
  • Holder: MEDA PHARMA GMBH & Co. KG - GERMANIA
  • Number: 8198/2006/05
  • Shelf life: 5 years

Pharmaceutical forms available for flecainide

Concentrations available for flecainide

  • 100mg
  • 150mg
  • 200mg
  • 50mg